Barclays »

C4 Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2024-03-31 $434k 53k 8.17
2023-12-31 $247k 44k 5.66
2023-09-30 $81k 44k 1.86
2023-06-30 $92k 33k 2.76
2023-03-31 $148k 47k 3.13
2022-12-31 $611k 104k 5.90
2022-09-30 $660k 75k 8.77
2022-06-30 $30k 4.0k 7.58
2022-03-31 $670k 28k 24.24